165
Views
1
CrossRef citations to date
0
Altmetric
Articles

Production and characterization of a fusion form of hepatitis E virus tORF2 capsid protein in Escherichia coli

ORCID Icon, , , , , ORCID Icon & show all

References

  • Ojha, N. K.; Lole, K. S. Hepatitis E Virus ORF1 Encoded Macro Domain Protein Interacts with Light Chain Subunit of Human Ferritin and Inhibits Its Secretion. Mol. Cell. Biochem. 2016, 417, 75–85. DOI: 10.1007/s11010-016-2715-0.
  • Kamili, S. Toward the Development of a Hepatitis E Vaccine. Virus Res. 2011, 161, 93–100. DOI: 10.1016/j.virusres.2011.05.008.
  • Li, S.; Zhang, J.; Xia, N. Lessons from Hepatitis E Vaccine Design. Curr. Opin. Virol. 2015, 11, 130–136. DOI: 10.1016/j.coviro.2015.04.003.
  • Zhou, Y.-H.; Purcell, R. H.; Emerson, S. U. A Truncated ORF2 Protein Contains the Most Immunogenic Site on ORF2: Antibody Responses to Non-Vaccine Sequences following Challenge of Vaccinated and Non-Vaccinated Macaques with Hepatitis E Virus. Vaccine 2005, 23, 3157–3165. DOI: 10.1016/j.vaccine.2004.12.020.
  • Capelli, N.; Dubois, M.; Pucelle, M.; Da Silva, I.; Lhomme, S.; Abravanel, F.; Chapuy-Regaud, S.; Izopet, J. Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity. Viruses 2020, 12, 139. DOI: 10.3390/v12020139.
  • Emerson, S. U.; Purcell, R. H. Recombinant Vaccines for Hepatitis E. Trends Mol. Med. 2001, 7, 462–466. (01)02106-2. DOI: 10.1016/S1471-4914(01)02106-2.
  • Emerson, S. U.; Clemente-Casares, P.; Moiduddin, N.; Arankalle, V. A.; Torian, U.; Purcell, R. H. Putative Neutralization Epitopes and Broad Cross-Genotype Neutralization of Hepatitis E Virus Confirmed by a Quantitative Cell-Culture Assay. J. Gen. Virol. 2006, 87, 697–704. DOI: 10.1099/vir.0.81545-0.
  • Montpellier, C.; Wychowski, C.; Sayed, I. M.; Meunier, J.-C.; Saliou, J.-M.; Ankavay, M.; Bull, A.; Pillez, A.; Abravanel, F.; Helle, F.; et al. Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein. Gastroenterology 2018, 154, 211–223.e8. DOI: 10.1053/j.gastro.2017.09.020.
  • Ankavay, M.; Montpellier, C.; Sayed, I. M.; Saliou, J.-M.; Wychowski, C.; Saas, L.; Duvet, S.; Aliouat-Denis, C.-M.; Farhat, R.; de Masson d’Autume, V.; et al. New Insights into the ORF2 Capsid Protein, a Key Player of the Hepatitis E Virus Lifecycle. Sci. Rep. 2019, 9, 6243. DOI: 10.1038/s41598-019-42737-2.
  • Okamoto, H. Culture Systems for Hepatitis E Virus. J. Gastroenterol. 2013, 48, 147–158. DOI: 10.1007/s00535-012-0682-0.
  • Kamili, S.; Spelbring, J.; Carson, D.; Krawczynski, K. Protective Efficacy of Hepatitis E Virus DNA Vaccine Administered by Gene Gun in the Cynomolgus Macaque Model of Infection. J. Infect. Dis. 2004, 189, 258–264. DOI: 10.1086/380801.
  • Guu, T. S. Y.; Liu, Z.; Ye, Q.; Mata, D. A.; Li, K.; Yin, C.; Zhang, J.; Tao, Y. J. Structure of the Hepatitis E Virus-like Particle Suggests Mechanisms for Virus Assembly and Receptor Binding. Proc. Natl. Acad. Sci. USA. 2009, 106, 12992–12997. DOI: 10.1073/pnas.0904848106.
  • Li, S. W.; Zhang, J.; Li, Y. M.; Ou, S. H.; Huang, G. Y.; He, Z. Q.; Ge, S. X.; Xian, Y. L.; Pang, S. Q.; Ng, M. H.; et al. A Bacterially Expressed Particulate Hepatitis E Vaccine: Antigenicity, Immunogenicity and Protectivity on Primates. Vaccine 2005, 23, 2893–2901. DOI: 10.1016/j.vaccine.2004.11.064.
  • Purcell, R. H.; Nguyen, H.; Shapiro, M.; Engle, R. E.; Govindarajan, S.; Blackwelder, W. C.; Wong, D. C.; Prieels, J. P.; Emerson, S. U. Pre-Clinical Immunogenicity and Efficacy Trial of a Recombinant Hepatitis E Vaccine. Vaccine 2003, 21, 2607–2615. DOI: 10.1016/S0264-410X(03)00100-2.
  • Huang, W. J.; Zhang, H. Y.; Harrison, T. J.; Lan, H. Y.; Huang, G. Y.; Wang, Y. C. Immunogenicity and Protective Efficacy in Rhesus Monkeys of a Recombinant ORF2 Protein from Hepatitis E Virus Genotype 4. Arch. Virol. 2009, 154, 481–488. DOI: 10.1007/s00705-009-0335-7.
  • Zhang, M.; Emerson, S. U.; Nguyen, H.; Engle, R.; Govindarajan, S.; Blackwelder, W. C.; Gerin, J.; Purcell, R. H. Recombinant Vaccine against Hepatitis E: Duration of Protective Immunity in Rhesus Macaques. Vaccine 2002, 20, 3285–3291. DOI: 10.1016/S0264-410X(02)00314-6.
  • Panda, S. K.; Nanda, S. K.; Zafrullah, M.; Ansari, I. H.; Ozdener, M. H.; Jameel, S. An Indian Strain of Hepatitis E Virus (HEV): Cloning, Sequence, and Expression of Structural Region and Antibody Responses in Sera from Individuals from an Area of High-Level HEV Endemicity. J. Clin. Microbiol. 1995, 33, 2653–2659. DOI: 10.1128/JCM.33.10.2653-2659.1995.
  • Tyagi, S.; Korkaya, H.; Zafrullah, M.; Jameel, S.; Lal, S. K. The Phosphorylated Form of the ORF3 Protein of Hepatitis E Virus Interacts with Its Non-Glycosylated Form of the Major Capsid Protein, ORF2. J. Biol. Chem. 2002, 277, 22759–22767. DOI: 10.1074/jbc.M200185200.
  • Ma, Y.; Lin, S.-Q.; Gao, Y.; Li, M.; Luo, W.-X.; Zhang, J.; Xia, N.-S. Expression of ORF2 Partial Gene of Hepatitis E Virus in Tomatoes and Immunoactivity of Expression Products. World J Gastroenterol 2003, 9, 2211–2215. DOI: 10.3748/wjg.v9.i10.2211.
  • He, J.; Tam, A. W.; Yarbough, P. O.; Reyes, G. R.; Carl, M. Expression and Diagnostic Utility of Hepatitis E Virus Putative Structural Proteins Expressed in Insect Cells. J. Clin. Microbiol. 1993, 31, 2167–2173. DOI: 10.1128/JCM.31.8.2167-2173.1993.
  • Jameel, S.; Zafrullah, M.; Ozdener, M. H.; Panda, S. K. Expression in Animal Cells and Characterization of the Hepatitis E Virus Structural Proteins. J. Virol. 1996, 70, 207–216. DOI: 10.1128/JVI.70.1.207-216.1996.
  • Schofield, D. J.; Purcell, R. H.; Nguyen, H. T.; Emerson, S. U. Monoclonal Antibodies That Neutralize HEV Recognize an Antigenic Site at the Carboxyterminus of an ORF2 Protein Vaccine. Vaccine 2003, 22, 257–267. DOI: 10.1016/j.vaccine.2003.07.008.
  • Purdy, M. A.; McCaustland, K. A.; Krawczynski, K.; Spelbring, J.; Reyes, G. R.; Bradley, D. W. Preliminary Evidence That a TrpE-HEV Fusion Protein Protects Cynomolgus Macaques against Challenge with Wild-Type Hepatitis E Virus (HEV). J. Med. Virol. 1993, 41, 90–94. DOI: 10.1002/jmv.1890410118.
  • Zhang, J. Z.; Ng, M. H.; Xia, N. S.; Lau, S. H.; Che, X. Y.; Chau, T. N.; Lai, S. T.; Im, S. W. Conformational Antigenic Determinants Generated by Interactions between a Bacterially Expressed Recombinant Peptide of the Hepatitis E Virus Structural Protein. J. Med. Virol. 2001, 64, 125–132. DOI: 10.1002/jmv.1027.
  • Im, S. W.; Zhang, J. Z.; Zhuang, H.; Che, X. Y.; Zhu, W. F.; Xu, G. M.; Li, K.; Xia, N. S.; Ng, M. H. A Bacterially Expressed Peptide Prevents Experimental Infection of Primates by the Hepatitis E Virus. Vaccine 2001, 19, 3726–3732. DOI: 10.1016/S0264-410X(01)00100-1.
  • Yarbough, P. O. Hepatitis E Virus. Advances in HEV Biology and HEV Vaccine Approaches. Intervirology 1999, 42, 179–184. DOI: 10.1159/000024978.
  • Arankalle, V. A.; Lole, K. S.; Deshmukh, T. M.; Srivastava, S.; Shaligram, U. S. Challenge Studies in Rhesus Monkeys Immunized with Candidate Hepatitis E Vaccines: DNA, DNA-Prime-Protein-Boost and DNA-Protein Encapsulated in Liposomes. Vaccine 2009, 27, 1032–1039. DOI: 10.1016/j.vaccine.2008.11.097.
  • Rai, V.; Upmanyu, V.; Mohd, G.; Kumar, R.; Koppad, S.; Ansari, A.; Bora, D. P.; Pandey, A. B.; Dhar, P.; Tiwari, A. K. Comparing the Efficiency of Different Escherichia Coli Strains in Producing Recombinant Capsid Protein of Porcine Circovirus Type 2. Mol. Cell. Probes. 2020, 52, 101556. DOI: 10.1016/j.mcp.2020.101556.
  • Wu, T.; Li, S. W.; Zhang, J.; Ng, M. H.; Xia, N. S.; Zhao, Q. Hepatitis E Vaccine Development: A 14 Year Odyssey. Hum. Hum. Vaccin. Immunother. 2012, 8, 823–827. DOI: 10.4161/hv.20042.
  • Boumaiza, M.; Carmona, F.; Poli, M.; Asperti, M.; Gianoncelli, A.; Bertuzzi, M.; Ruzzenenti, P.; Arosio, P.; Marzouki, M. N. Production and Characterization of Functional Recombinant Hybrid Heteropolymers of Camel Hepcidin and Human Ferritin H and L Chains. Protein Eng. Des. Sel. 2017, 30, 77–84. DOI: 10.1093/protein/gzw066.
  • Leone, S.; Pica, A.; Merlino, A.; Sannino, F.; Temussi, P. A.; Picone, D. Sweeter and Stronger: Enhancing Sweetness and Stability of the Single Chain Monellin MNEI through Molecular Design. Sci. Rep. 2016, 6, 34045–34010. DOI: 10.1038/srep34045.
  • Arankalle, V. A.; Lole, K. S.; Deshmukh, T. M.; Chobe, L. P.; Gandhe, S. S. Evaluation of Human (Genotype 1) and Swine (Genotype 4)-ORF2-Based ELISAs for anti-HEV IgM and IgG Detection in an Endemic Country and Search for Type 4 Human HEV Infections. J. Viral. Hepat. 2007, 14, 435–445. DOI: 10.1111/j.1365-2893.2006.00801.x.
  • OriginLab – Origin and OriginPro – Data Analysis and Graphing Software. Available at: https://www.originlab.com/ (accessed Apr 6, 2020).
  • Rani, D.; Saxena, R.; Nayak, B.; Srivastava, S. Cloning and Expression of Truncated ORF2 as a Vaccine Candidate against Hepatitis E Virus. 3 Biotech. 2018, 8, 414. DOI: 10.1007/s13205-018-1437-2.
  • Taherkhani, R.; Makvandi, M.; Farshadpour, F. Development of Enzyme-Linked Immunosorbent Assays Using 2 Truncated ORF2 Proteins for Detection of IgG Antibodies against Hepatitis E Virus. Ann. Lab. Med. 2014, 34, 118–126. DOI: 10.3343/alm.2014.34.2.118.
  • Wang, H.; Zhang, W.; Gu, H.; Chen, W.; Zeng, M.; Ji, C.; Song, R.; Zhang, G. Identification and Characterization of Two Linear Epitope Motifs in Hepatitis E Virus ORF2 Protein. PLOS One. 2017, 12, e0184947. DOI: 10.1371/journal.pone.0184947.
  • Malhotra, A. Tagging for Protein Expression. Meth. Enzymol. 2009, 463, 239–258. DOI: 10.1016/S0076-6879(09)63016-0..
  • Costa, S.; Almeida, A.; Castro, A.; Domingues, L. Fusion Tags for Protein Solubility, Purification and Immunogenicity in Escherichia Coli: The Novel Fh8 System. Front. Microbiol. 2014, 5, 63. DOI: 10.3389/fmicb.2014.00063..
  • Kimple, M. E.; Brill, A. L.; Pasker, R. L. Overview of Affinity Tags for Protein Purification. Curr Protoc Protein Sci 2013, 73, 9.9.1–9.9.23. DOI: 10.1002/0471140864.ps0909s73..
  • Zafrullah, M.; Khursheed, Z.; Yadav, S.; Sahgal, D.; Jameel, S.; Ahmad, F. Acidic PH Enhances Structure and Structural Stability of the Capsid Protein of Hepatitis E Virus. Biochem. Biophys. Res. Commun. 2004, 313, 67–73. DOI: 10.1016/j.bbrc.2003.11.088.
  • Wang, W. Lyophilization and Development of Solid Protein Pharmaceuticals. Int. J. Pharm. 2000, 203, 1–60. DOI: 10.1016/S0378-5173(00)00423-3.
  • Gulati, B. R.; Cameron, K. T.; Seal, B. S.; Goyal, S. M.; Halvorson, D. A.; Njenga, M. K. Development of a Highly Sensitive and Specific Enzyme-Linked Immunosorbent Assay Based on Recombinant Matrix Protein for Detection of Avian Pneumovirus Antibodies. J. Clin. Microbiol. 2000, 38, 4010–4014. DOI: 10.1128/JCM.38.11.4010-4014.2000.
  • Gecchele, E.; Merlin, M.; Brozzetti, A.; Falorni, A.; Pezzotti, M.; Avesani, L. A Comparative Analysis of Recombinant Protein Expression in Different Biofactories: Bacteria, Insect Cells and Plant Systems. J. Vis. Exp. 2015, 97, 52459. DOI: 10.3791/52459.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.